510(k) device
Cochlear Osia® System
Cochlear · Active Implantable Bone Conduction Hearing System (PFO, Class II) · First FDA decision Aug 18, 2023, newest Aug 18, 2023Hearing loss
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
4
Naming "Cochlear Osia"
MAUDE reports
3,100
Brand "Cochlear Osia", since 2015
PubMed studies
31
Mentioning "Cochlear Osia"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Cochlear Osia® System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K231204 · Decided Aug 18, 2023 · 113 days after receipt
Device type: Active Implantable Bone Conduction Hearing System (PFO) · Otolaryngology (ENT)
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Cochlear Osia", any status and sponsor, newest update first.
CochlearNot on our public-company list
NCT07130136 · 20 participants (planned) · Start Jul 24, 2026 · Primary completion Nov 2028
Device: Cochlear™ Osia® System; Cochlear™ Baha® System · For: Bone Conduction; Hearing Loss, Conductive; Hearing Loss, Mixed
Sites: London, United Kingdom; Nottingham, United Kingdom; Sheffield, United Kingdom
3 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Cochlear Osia", and for the whole product code for context.
This brand
3,100 reports: 94 malfunction, 3,005 injury, 1 death
Whole product code PFO
3,616 reports: 378 malfunction, 3,236 injury, 1 death
Newest reports for this brand
6000034-2026-03881 · Received Oct 30, 2026
Device type: Active Implantable Bone Conduction Hearing System (PFO)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Insufficient Information
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Cochlear Osia"[tiab]. The summary above synthesizes these.
- How I do it: Cochlear Osia 2 System surgery placement.
Soloperto D, Dallari V, Molteni G · Eur Arch Otorhinolaryngol · 2023
- Innovative surgical approaches for the Osia® 2 System.
Lee JW, Lee HS, Seo YJ · Acta Otolaryngol · 2025
- Early Osia® 2 bone conduction hearing implant experience: Nationwide controlled-market release data and single-center outcomes.
Goldstein MR, Bourn S, Jacob A · Am J Otolaryngol · 2021
- A New Active Osseointegrated Implant System in Patients with Single-Sided Deafness.
Willenborg K, Avallone E, Maier H, et al. · Audiol Neurootol · 2022Observational Study, Research Support, Non-U.S. Gov't
- The impact of the Cochlearࡊ Osia® 2 System on patients with mixed or conductive hearing loss: A comparison with Cochlearࡊ Baha® Attract System outcomes.
Park KS, Kim HC, Lee S, et al. · Sci Prog · 2024Comparative Study, Research Support, Non-U.S. Gov't
- Outcomes of Osia 2 Implantation With and Without Concurrent Microtia Reconstruction.
Nelson L, Losorelli S, Chang KW, et al. · Otolaryngol Head Neck Surg · 2026
- Magnetic Resonance Imaging Artifact Associated With Transcutaneous Bone Conduction Implants: Cholesteatoma and Vestibular Schwannoma Surveillance.
Nassiri AM, Messina SA, Benson JC, et al. · Otolaryngol Head Neck Surg · 2024
- Comparative Clinical Effectiveness and Cost-Effectiveness of the Cochlear Osia System and Baha Attract System in Patients with Conductive or Mixed Hearing Loss or Single-Sided Deafness.
Brunner M, Schou M, Briggs RJ, et al. · J Mark Access Health Policy · 2024
- Outcomes with transcutaneous bone conduction implants in patients with mixed hearing loss.
Daher GS, Thompson ES, Thomason M, et al. · Am J Otolaryngol · 2025
- Single-Stage Ear Reconstruction Simultaneous With Piezoelectric Osia® Bone Conduction Implantation.
Leonard C, Oberoi M, Belza C, et al. · Ann Plast Surg · 2025Research Support, Non-U.S. Gov't
- [Prediction of speech understanding with the transcutaneous partially implantable bone conduction hearing system Osia®. German Version].
Arndt S, Wesarg T, Aschendorff A, et al. · HNO · 2024English Abstract
- Clinical performance of the Osiaࡊ system, a new active osseointegrated implant system. Results from a prospective clinical investigation.
Goycoolea M, Ribalta G, Tocornal F, et al. · Acta Otolaryngol · 2020
Other devices of this type
Also filed under product code PFO.
- BONEBRIDGE System, SAMBA 2 BB, SYMFIT 8.0, SAMBA 2 GO, SAMBA 2 RemoteMed-El Elektromedizinische Geraete GmbH · De Novo 2020
- Cochlear Osia® 3(I) Sound ProcessorCochlear Americas · 510(k) 2026
- Sentio Ti Implant KitOticon Medical AB · 510(k) 2024
- Cochlear Osia SystemCochlear Americas · 510(k) 2024
- Cochlear Osia 2 SystemCochlear Americas · 510(k) 2022
- BCI 602 Lifts (1 mm)Med-El Elektromedizinische Geraete GmbH · 510(k) 2020
- Cochlear Osia OSI200 ImplantCochlear Americas · 510(k) 2019
- Cochlear Osia OSI100 ImplantCochlear Americas · 510(k) 2019
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.